Start-up focuses on nerve imaging

Article

Nervonix, a medical R&D company headquartered in Bozeman, MT, is cultivating technology that generates noninvasive 2D images of peripheral nerves. The images might ultimately be used to identify the location of nerves, providing the basis for pain

Nervonix, a medical R&D company headquartered in Bozeman, MT, is cultivating technology that generates noninvasive 2D images of peripheral nerves. The images might ultimately be used to identify the location of nerves, providing the basis for pain diagnosis and management by anesthesiologists, surgeons, and other clinicians, according to the company. A portable device is being designed to deliver real-time, high-resolution nerve images from a patient's bedside or the operating table. Nervonix is collaborating with Battelle Memorial Institute to develop the technology into a viable product, which could be commercially available as early as mid-2004, according to Nervonix. The company is now looking for commercial partners, OEMs, and distributors to assist in its development and marketing efforts.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.